EICHORCondition: HER2 + Breast Cancer · Sponsor: Priyanka Sharma
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
This description comes directly from the study's public registry record.
Study Coordinator · 913-588-6079 · PRO-HER2@kumc.edu
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Stage I-IV HER2-positive breast cancer Exclusion Criteria: * None
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| KUCC - Indian Creek | Overland Park, Kansas, United States | Active Not Recruiting |
| KUCC - Overland Park | Overland Park, Kansas, United States | Active Not Recruiting |
| KUCC - Briarcliff | Westwood, Kansas, United States | Active Not Recruiting |
| KUCC - Olathe | Westwood, Kansas, United States | Active Not Recruiting |
| The University of Kansas Cancer Center | Westwood, Kansas, United States | Recruiting |
| KUCC - Lee's Summit | Lee's Summit, Missouri, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06603597